ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $94,336,226 | +3.2% | 4,604,013 | +0.1% | 0.00% | 0.0% |
Q2 2023 | $91,400,569 | +17.7% | 4,599,928 | +1.5% | 0.00% | 0.0% |
Q1 2023 | $77,640,422 | -5.2% | 4,532,424 | +8.3% | 0.00% | 0.0% |
Q4 2022 | $81,930,626 | +50.2% | 4,186,542 | +22.5% | 0.00% | 0.0% |
Q3 2022 | $54,544,000 | +18.1% | 3,417,511 | +1.8% | 0.00% | +100.0% |
Q2 2022 | $46,172,000 | -13.1% | 3,355,491 | +0.2% | 0.00% | 0.0% |
Q1 2022 | $53,118,000 | -26.3% | 3,349,160 | +1.5% | 0.00% | -50.0% |
Q4 2021 | $72,064,000 | -25.7% | 3,301,138 | +1.7% | 0.00% | 0.0% |
Q3 2021 | $97,004,000 | -31.7% | 3,245,388 | +1.2% | 0.00% | -50.0% |
Q2 2021 | $142,072,000 | +10.0% | 3,207,765 | +10.2% | 0.00% | +33.3% |
Q1 2021 | $129,186,000 | +15.6% | 2,911,574 | +42.9% | 0.00% | 0.0% |
Q4 2020 | $111,734,000 | +154.8% | 2,037,459 | +6.2% | 0.00% | +200.0% |
Q3 2020 | $43,844,000 | +8.6% | 1,918,005 | -0.5% | 0.00% | 0.0% |
Q2 2020 | $40,358,000 | +55.8% | 1,928,284 | +3.8% | 0.00% | 0.0% |
Q1 2020 | $25,907,000 | -36.7% | 1,857,107 | +3.3% | 0.00% | 0.0% |
Q4 2019 | $40,908,000 | +126.7% | 1,797,400 | +16.1% | 0.00% | 0.0% |
Q3 2019 | $18,044,000 | -19.9% | 1,548,787 | +3.1% | 0.00% | 0.0% |
Q2 2019 | $22,536,000 | +1.4% | 1,502,349 | +18.6% | 0.00% | 0.0% |
Q1 2019 | $22,223,000 | +31.9% | 1,266,938 | +11.4% | 0.00% | 0.0% |
Q4 2018 | $16,852,000 | -28.8% | 1,137,070 | +18.3% | 0.00% | 0.0% |
Q3 2018 | $23,671,000 | +42.0% | 961,464 | +13.2% | 0.00% | 0.0% |
Q2 2018 | $16,671,000 | +31.9% | 849,284 | +26.0% | 0.00% | 0.0% |
Q1 2018 | $12,637,000 | – | 674,019 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |